Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.

Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH.

Am J Respir Crit Care Med. 1995 Jun;151(6):1900-6.

PMID:
7767538
2.

IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.

Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, Hamid Q.

Am J Respir Cell Mol Biol. 1997 Jul;17(1):17-24.

PMID:
9224205
3.

Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.

Masuyama K, Till SJ, Jacobson MR, Kamil A, Cameron L, Juliusson S, Lowhagen O, Kay AB, Hamid QA, Durham SR.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):610-7.

PMID:
9802369
4.

Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods.

Jacobson MR, Juliusson S, Löwhagen O, Balder B, Kay AB, Durham SR.

Clin Exp Allergy. 1999 Oct;29(10):1347-55.

PMID:
10520055
5.

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.

Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.

J Allergy Clin Immunol. 2001 Apr;107(4):627-33.

PMID:
11295650
6.

In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.

Ghaffar O, Christodoulopoulos P, Lamkhioued B, Wright E, Ihaku D, Nakamura Y, Frenkiel S, Hamid Q.

Clin Exp Allergy. 2000 Jan;30(1):86-93.

PMID:
10606935
7.

Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, Lowhagen O, Hamid Q, Durham SR.

Immunology. 1994 Jun;82(2):192-9.

8.

Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.

Cameron LA, Durham SR, Jacobson MR, Masuyama K, Juliusson S, Gould HJ, Lowhagen O, Minshall EM, Hamid QA.

J Allergy Clin Immunol. 1998 Mar;101(3):330-6.

PMID:
9525448
9.

Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.

Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, Hamid Q, Löwhagen O, Durham SR.

Clin Exp Allergy. 1994 Oct;24(10):930-9.

PMID:
7842362
10.
11.

Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.

Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT.

Clin Exp Allergy. 2005 Dec;35(12):1608-14.

PMID:
16393327
12.

Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.

Kleinjan A, Holm AF, Dijkstra MD, Boks SS, Severijnen L, Mulder PG, Fokkens WJ.

Clin Exp Allergy. 2000 Oct;30(10):1476-85.

PMID:
10998026
13.

Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.

Meltzer EO, Orgel HA, Rogenes PR, Field EA.

J Allergy Clin Immunol. 1994 Oct;94(4):708-15.

PMID:
7930304
14.

Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis.

Grossman J, Banov C, Bronsky EA, Nathan RA, Pearlman D, Winder JA, Ratner PH, Mendelson L, Findlay SR, Kral KM, et al.

Pediatrics. 1993 Oct;92(4):594-9.

PMID:
8414833
15.

Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.

Di Lorenzo G, Gervasi F, Drago A, Esposito Pellitteri M, Di Salvo A, Cosentino D, Potestio M, Colombo A, Candore G, Mansueto S, Caruso C.

Clin Exp Allergy. 1999 Oct;29(10):1367-77.

PMID:
10520057
16.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
17.

Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy.

Till SJ, Jacobson MR, O'Brien F, Durham SR, KleinJan A, Fokkens WJ, Juliusson S, Löwhagen O.

Allergy. 2001 Feb;56(2):126-31.

18.

Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.

Weido AJ, Reece LM, Alam R, Cook CK, Sim TC.

Ann Allergy Asthma Immunol. 1996 Nov;77(5):407-15.

PMID:
8933780
19.
20.

A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology.

Meltzer EO, Orgel HA, Bronsky EA, Furukawa CT, Grossman J, LaForce CF, Lemanske RF Jr, Paull BD, Pearlman DS, Ratner PH, et al.

J Allergy Clin Immunol. 1990 Aug;86(2):221-30.

PMID:
2200821
Items per page

Supplemental Content

Write to the Help Desk